16th Dec 2008 15:46
RNS Number : 2439K
Ark Therapeutics Group PLC
16 December 2008
Ark Therapeutics Group plc
16 December 2008
Notification of Major Interests in Shares
1 Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
ARK THERAPEUTICS GROUP PLC
2. Reason for the notification (please tick the appropriate box or boxes):
|
An acquisition or disposal of voting rights:
|
(x)
|
|
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
|
( )
|
|
An event changing the breakdown of voting rights:
|
( )
|
|
Other
|
( )
|
3. Full name of person(s) subject to the notification obligation:
J O Hambro Capital Management Group Limited
4. Full name of shareholder(s) (if different from 3):
N/A
5. Date of the transaction and date on which the threshold is crossed or reached if different:
10 December 2008
6. Date on which issuer notified:
16 December 2008
7. Threshold(s) that is/are crossed or reached:
5%
8. Notified details:
A: Voting rights attached to shares
|
Class/type of shares:
|
Ordinary
Sedol: 3425172
|
|
|
|
|
Situation previous to the triggering transaction:
|
|
|
|
|
|
Number of shares:
|
9,401,567
|
|
|
|
|
Number of voting rights:
|
9,401,567
|
|
|
|
|
Resulting situation after the triggering transaction:
|
|
|
|
|
|
Number of shares:
|
11,701,567
|
|
|
|
|
Number of voting rights:
|
|
|
|
|
|
Direct:
|
11,701,567
|
|
|
|
|
Indirect:
|
|
|
|
|
|
% of voting rights:
|
|
|
|
|
|
Direct:
|
5.70%
|
|
|
|
|
Indirect:
|
|
B: Financial Instruments: N/A
|
Resulting situation after the triggering transaction:
|
|
|
|
|
|
Type of financial instrument:
|
|
|
|
|
|
Expiration date:
|
|
|
|
|
|
Exercise/conversion period/date:
|
|
|
|
|
|
Number of voting rights that may be acquired if the instrument is exercised/ converted:
|
|
|
|
|
|
% of voting rights:
|
|
Total (A+B):
|
Number of voting rights:
|
11,701,567
|
|
|
|
|
% of voting rights:
|
5.70%
|
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
N/A
Proxy Voting:
10. Name of the proxy holder:
-
11. Number of voting rights proxy holder will cease to hold:
-
12. Date on which proxy holder will cease to hold voting rights:
-
13. Additional information:
-
14. Contact name:
Bonita Guntrip
15. Contact telephone number:
020 7747 5681
16. Contact name and telephone at issuer:
MARTYN WILLIAMS
Company Secretary
Ark Therapeutics Group plc
020 7388 7722
16 December 2008
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
PVG.L